Rapid Tricyclic antidepressant (TCA) Test is an immunochromatography based one step in vitro test. It is designed for qualitative determination of tricyclic anti-depressant in human urine specimens.
Tricyclic antidepressants, also known now as cyclic antidepressants or TCAs, should be used cautiously in patients with seizures since they can increase the risk of seizures. TCAs may worsen urinary retention and narrow angle glaucoma. Abnormal heart rhythms and sexual dysfunction have also been associated with TCAs. Symptoms of overdose may include: sedation, difficulty thinking, hallucinations, serious changes in heart rhythm, low blood pressure, seizures, hyperthermia, and dilated pupils. TCA can be detected in your urine in 5 days after consumption. Some other medicines can interfere with this test, causing a false-positive for TCAs. These include carbamazepine, quetiapine, diphenhydramine, thioridazine, chlorpromazine, and cyclobenzaprine.